Table 4.
Mathematical function | Compounds tested | |
---|---|---|
Covariate relationshipa | ||
Continuous covariate | ||
No relationship | Citalopram, DMAG, Escitalopram, Olanzapine, Perphenazine, Risperidone, Ziprasidone | |
Additive | Citalopram, DMAG, Olanzapine, Perphenazine | |
Proportional | Citalopram, DMAG, Escitalopram, Olanzapine | |
Exponential | Citalopram, DMAG, Escitalopram, Perphenazine, Risperidone, Olanzapine, Ziprasidone | |
Power-law | Citalopram, Escitalopram, Olanzapine, Perphenazine | |
Michaelis–Menten | DMAG | |
Discrete | ||
No relationship | Citalopram, DMAG, Escitalopram, Olanzapine, Perphenazine, Risperidone, Ziprasidone | |
Additive | Citalopram, DMAG, Escitalopram, Olanzapine, Perphenazine, Ziprasidone | |
Proportional | Perphenazine | |
Exponential | Risperidone, Perphenazine | |
Type of inter-individual variabilityb | ||
No relationship | Citalopram, DMAG, Escitalopram, Olanzapine, Perphenazine, Risperidone, Ziprasidone | |
Exponential | Citalopram, DMAG,Escitalopram, Olanzapine, Perphenazine, Risperidone, Ziprasidone | |
Type of residual variabilityc | ||
Additive | Citalopram, DMAG, Escitalopram, Olanzapine, Perphenazine, Risperidone, Ziprasidone | |
Proportional | Citalopram, DMAG, Escitalopram, Olanzapine, Perphenazine, Risperidone, Ziprasidone | |
Combined additive and proportional | Citalopram, DMAG, Escitalopram, Olanzapine, Perphenazine, Risperidone, Ziprasidone |
aModification of a typical value for the example of clearance of the ith individual by the jth covariate or where x i,j is the value of the jth covariate for the ith patient, is the median value of the jth covariate, is the category (counting) number of the jth covariate for the ith patient, and is a parameter for functional form n that describe the relationship of the jth covariate
bInter-individual function forms considered for the example of the clearance of the ith individual. The takes a standard normal distribution with standard deviation
cResidual variability function forms considered. The variable Y i,j is the jth observation for the ith patient, F i,j is the corresponding model prediction, and and take standard normal distributions with variances and , respectively